Assignment Vinge assists Nuevolution in connection with Amgen’s cash offer

May 22, 2019

Vinge has assisted Nuevolution AB (publ) (“Nuevolution”) in connection with the cash offer to the shareholders in Nuevolution by Amgen Inc. (“Amgen”).

Nuevolution is a molecule drug discovery biotech company, listed on Nasdaq Stockholm. 

Amgen is one of the world’s leading biotechnology companies, with a vision deeply rooted in innovative science. Amgen’s shares are listed on Nasdaq in the United States.

Amgen offers SEK 32.50 in cash for every share in Nuevolution. The offer value amounts to approximately SEK 1,610 million.
 
Vinge’s team has primarily consisted of David Andersson, Dain Hård Nevonen, Ludvig Frithiof and William Kåge.

Employment law podcast – our first episode in English

By popular request, here is our very first English-language episode of Vinge's employment law podcast Arbetsrättspodden.
November 28, 2019

Viveka Classon new partner in Stockholm

Viveka Classon has been elected as a new partner at Vinge’s Stockholm office.
November 14, 2019

Maria-Pia Hope wins the Swedish Bar Association’s award for outstanding work within the legal profession

For the eighth year in a row, the Swedish Bar Association has issued the award for outstanding achievements within the legal profession. In 2019, the award goes to Maria-Pia Hope, Managing Partner at Advokatfirman Vinge.
October 25, 2019